Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.82)
# 1,921
Out of 5,090 analysts
26
Total ratings
62.5%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $489.31 | -29.70% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $22.98 | +132.81% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $30.76 | +30.04% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $34.41 | -12.82% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.98 | +42.14% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $21.34 | -25.02% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.03 | +52,658.62% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $1.15 | +39,900.00% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.15 | +1,519.05% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $38.77 | -58.73% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $5.58 | +706.45% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $489.31
Upside: -29.70%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $22.98
Upside: +132.81%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $30.76
Upside: +30.04%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $34.41
Upside: -12.82%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.98
Upside: +42.14%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $21.34
Upside: -25.02%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.03
Upside: +52,658.62%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $1.15
Upside: +39,900.00%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.15
Upside: +1,519.05%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $38.77
Upside: -58.73%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $5.58
Upside: +706.45%